Showing results (941-950 of 1,596) with videos related to

Sort By:
Pageof 160
JAMA Psychiatry|June 7, 2013
Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuitMohammed R Milad, Sharon C Furtak, Jennifer L Greenberg, et al.
JAMA Psychiatry|November 1, 2013
Addressing risks to advance mental health researchAna S Iltis, Sahana Misra, Laura B Dunn, et al.
JAMA Psychiatry|November 8, 2013
In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopyFei Du, Alissa J Cooper, Thida Thida, et al.
JAMA Psychiatry|November 8, 2013
Functional magnetic resonance imaging of impaired sensory prediction in schizophreniaSukhwinder S Shergill, Thomas P White, Daniel W Joyce, et al.
JAMA Psychiatry|October 18, 2013
Brainstem aminergic nuclei and late-life depressive symptomsRobert S Wilson, Sukriti Nag, Patricia A Boyle, et al.
JAMA Psychiatry|September 27, 2013
Preterm birth and mortality and morbidity: a population-based quasi-experimental studyBrian M D'Onofrio, Quetzal A Class, Martin E Rickert, et al.
JAMA Psychiatry|August 23, 2013
Antipsychotics and the risk of type 2 diabetes mellitus in children and youthWilliam V Bobo, William O Cooper, C Michael Stein, et al.
JAMA Psychiatry|August 23, 2013
Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy studyCamilo de la Fuente-Sandoval, Pablo León-Ortiz, Mariana Azcárraga, et al.
JAMA Psychiatry|October 11, 2013
Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophreniaNina V Kraguljac, David M White, Meredith A Reid, et al.
JAMA Psychiatry|September 20, 2013
Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleusRobert H Pietrzak, Jean-Dominique Gallezot, Yu-Shin Ding, et al.
Pageof 160